Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (20)
  • 2024 (21)
  • 2023 (47)
  • 2022 (65)
  • 2021 (57)
  • 2020 (8)
  • 2019 (6)
  • 2018 (1)
  • 2017 (3)
  • 2003 (1)

Subject

  • Drug Trafficking (4012)
  • Synthetic drugs (1065)
  • Guns/Weapons (990)
  • OCDETF/Task Force (810)
  • Fake Pills (655)
  • Arrests/Convictions - Major (604)
  • Guilty Plea (530)
  • Seizures (Drugs/Property) (457)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (268)
  • Take Back Day (246)
  • Diversion Division (242)
  • Task Forces/Task Force Officers (231)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Campaigns (8)
  • Other (8)
  • Counterfeit Pills (6)
  • Critical Incident (6)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Intelligence Division - Intelligence Products (5)

Drug Name

  • Oxycodone (47)
  • Opioids (46)
  • Fentanyl (28)
  • Synthetic Opioids (13)
  • Hydromorphone (12)
  • Benzodiazepines (7)
  • Morphine (7)
  • Cocaine (5)
  • Methamphetamine (5)
  • Heroin (3)
  • Ketamine (3)
  • Methadone (3)
  • Steroids (3)
  • Amphetamines (2)
  • GHB (1)
  • Marijuana (Cannabis) (1)
  • Marijuana Concentrates (1)

Field Division

  • Washington, DC (36)
  • St. Louis (32)
  • New York (21)
  • Chicago (19)
  • Miami (17)
  • Atlanta (12)
  • New Jersey (11)
  • Sede (10)
  • El Paso (9)
  • Dallas (8)
  • Houston (7)
  • San Francisco (7)
  • Seattle (7)
  • Louisville (5)
  • New England (5)
  • San Diego (5)
  • Los Angeles (4)
  • New Orleans (4)
  • Rocky Mountain (4)
  • Omaha (2)
  • Philadelphia (2)
  • Phoenix (2)
Clear All Results
PRESS RELEASE

U.S. Navy Petty Officer Pleads Guilty to Role in Multi-State Anabolic Steroid Trafficking Network

Junio 08, 2021
NORFOLK, Va. – Today, a Jacksonville, Florida man was the sixth and final defendant to enter a guilty plea for his role in a multi-state anabolic steroid conspiracy that operated in multiple states across the country. According to court documents, law enforcement received information in February 2020 that Erik Eckert...
Junio 08, 2021
PRESS RELEASE

Manager of Pain Clinic, Her Boyfriend, and Customers Facing Federal Charges for a Drug Distribution Conspiracy

Mayo 19, 2021
Baltimore, MD – A criminal complaint has been filed charging the manager of a pain clinic, her boyfriend, and several customers with conspiracy to distribute controlled substances, including oxycodone and oxymorphone. The defendants charged in the criminal complaint are: Monica Raynette Clark age 31, of Waldorf, Maryland; Michael Tyrone Scott...
Mayo 19, 2021
PRESS RELEASE

Bluefield Doctor Sentenced to Federal Prison on Misbranding Charge

Mayo 13, 2021
ABINGDON, Va. – A family medicine physician in Bluefield, Virginia, was sentenced yesterday to one month in prison on a charge of misbranding Schedule II controlled substances to three individuals, two of whom his office staff called “back door patients.” According to court documents, between December 2014 and January 2016...
Mayo 13, 2021
PRESS RELEASE

Dark Web Vendor of Opioids and Counterfeit U.S. Currency Pleads Guilty

Mayo 12, 2021
ALEXANDRIA, Va. – A Utica, New York man pleaded guilty yesterday to charges relating to his sale of over $1.2 million in opioid pills and counterfeit U.S. currency on multiple dark web criminal marketplaces. According to court documents, from around October 2016 through February 2021, Albie Pagan, 65, operated under...
Mayo 12, 2021
PRESS RELEASE

Albuquerque company agrees to $240,000 settlement relating to Controlled Substances Act claims

Marzo 30, 2021
ALBUQUERQUE, N.M. – Acting U.S. Attorney for the District of New Mexico Fred J. Federici has announced that Albuquerque Health Services (AHS) has agreed to a $240,000 settlement relating to civil claims brought by the Department of Justice on behalf of the United States Drug Enforcement Administration (DEA). AHS operates...
Marzo 30, 2021
PRESS RELEASE

Prison healthcare company agrees to $215,000 settlement relating to Controlled Substances Act claims

Marzo 30, 2021
ALBUQUERQUE, N.M. – Acting U.S. Attorney for the District of New Mexico Fred J. Federici has announced that Centurion Correctional Healthcare New Mexico has agreed to a $215,000 settlement relating to civil claims brought by the Department of Justice on behalf of the United States Drug Enforcement Administration (DEA). Centurion...
Marzo 30, 2021
PRESS RELEASE

San Antonio Physician Agrees to Pay $350,000 to Resolve Allegations that he Pre-Signed Prescriptions and Issued Prescriptions Without Appropriate Examinations

Marzo 09, 2021
SAN ANTONIO - Doctor Hugo A. Rojas, owner of Hugo A. Rojas, M.D., P.A., and Family Clinics of San Antonio, has agreed to pay $350,000.00 under a civil settlement to resolve allegations he violated certain provisions of the Controlled Substances Act (CSA) and the False Claims Act (FCA), announced Drug...
Marzo 09, 2021
PRESS RELEASE

DEA Washington Division Releases 2020 National Drug Threat Assessment for D.C., Maryland, and Virginia Communities

Marzo 02, 2021
Washington, D.C. – Today, DEA Acting Administrator D. Christopher Evans, and Special Agent in Charge of the DEA Washington Division, Jarod Forget, announce the release of the 2020 National Drug Threat Assessment – DEA’s annual publication outlining the threats posed to the U.S. by domestic and international drug trafficking and...
Marzo 02, 2021
PRESS RELEASE

Justice Department files lawsuit against Creve Coeur pharmacist for Controlled Substances Act violations

Febrero 24, 2021
ST. LOUIS – In a complaint filed February 23, 2021, by the U.S. Attorney’s Office for the Eastern District of Missouri, the government alleges Elizabeth Dembo unlawfully dispensed controlled substances to patients during her time as the pharmacist-in-charge of Olive Street Pharmacy, LLC. The retail pharmacy is located in the...
Febrero 24, 2021
PRESS RELEASE

Pharmaceutical Distributor Vistapharm, Inc. Agrees To Pay $325,000 To Resolve Alleged Violations Of The Controlled Substances Act

Febrero 02, 2021
TAMPA, Fla. - Vistapharm, Inc. has agreed to pay the United States $325,000 to resolve allegations that Vistapharm violated the Controlled Substances Act (CSA) by failing to maintain records required by the CSA. In addition to paying a civil penalty, Vistapharm has agreed to sign separately a Memorandum of Agreement...
Febrero 02, 2021
Showing 201 - 210 of 229 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 15
  • Página 16
  • Página 17
  • Página 18
  • Página 19
  • Página 20
  • Current page 21
  • Página 22
  • Página 23
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster